According to The Block, Hyperliquid’s大宗交易 layer Silhouette officially launched its request-for-quote (RFQ) system on mainnet on Tuesday, initially supporting Payward’s tokenized equities framework, xStocks. Traders can request quotes from integrated market makers, who then submit bids; the winning quote settles on-chain, enabling round-the-clock, large-volume trades without requiring a dedicated order book. Tokens meeting specified trading volume thresholds may later be upgraded to standalone HyperCore markets. Since its launch in June 2025, xStocks has processed over $40 billion in trading volume, with approximately $20 billion settled on-chain, serving over 200,000 holders and currently holding a market cap of around $620 million, making it the third-largest tokenized equities issuer globally.
Silhouette Launches RFQ Trading System on Hyperliquid Mainnet, Initially Supporting xStocks Tokenized Stocks
TechFlowShare
Silhouette, Hyperliquid’s institutional trading layer, has launched an RFQ system on mainnet, initially supporting xStocks tokenized stocks. Traders can request quotes from market makers, with winning bids settled on-chain. This enables large-volume, 24/7 trading without order books. xStocks has seen over $40 billion in trading volume since June 2025, with $20 billion settled on-chain. The tokenized stock platform has 200,000 holders and a $620 million market cap, ranking third globally. Increased trading activity is expected as more assets meet volume thresholds for HyperCore upgrades.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.